Janet has over 20 years of experience in the pharmaceutical/biotech industry with both large and small molecules. She has had various roles and responsibilities within clinical development. She was an integral member, author, and facilitator of several submissions for market authorization in multiple therapeutic areas at both GSK and Janssen. She is adept at strategic management and is results driven with a breadth of expertise from Phase 1 (including first in human), through Phase 4 studies. Janet has a clinical background in nursing, has a MBA and is a Wharton, School of Business, graduate from the University of Pennsylvania.